-This marks the fourth approval of Novavax´s updated COVID-19 vaccine globally, following approvals ...

On November 28th, the board of directors decided to invest in the expansion of L HOUSE, a vaccine ma...

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Afr...

SK bioscience plans to introduce the only updated protein-based non-mRNA, COVID vaccine for South Ko...

First among South Korea’s clinical trial sample analysis institutions, SK bioscience implements a La...

-Ana Brnabi?, Prime Minister of Serbia visited the SK bioscience headquarters.-SK bioscience signed ...

-SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collabora...

-SKYCellflu, the world’s first cell culture-based influenza vaccine obtaining WHO’s PQ, will be deli...

-SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation an...

SK bioscience donated to support the local community where L House, SK bioscience’s vaccine manufact...

SK bioscience identified 11 top-priority issues by adopting Double Materiality Assessment. Company e...

-Jaeyong Ahn, the CEO of SK bioscience, virtually joined the WHO workshop with representatives of gl...